Thus, this study suggests that intervention with a V2R antagonist should be initiated early in ADPKD and that it might be necessary to increase the dosage of this drug further later in the disease to reduce cyst growth [77]. Here, AVPR2 is linked to autosomal dominant polycystic kidney disease.